AUMED representatives participated in the XL. Congress of Slovak and Czech allergists and clinical immunologists, which took place from October 22 to 25, 2025 in Horní Smokovec. As in 2023, AUMED had its own promotional stand at the congress, focused mainly on the immunological preparation TFI based on transfer factor, which was a huge success. In the form of posters, leaflets and personal interviews, we shared with the professional public our successes in the development of the preparation and ongoing clinical trials.
We believe that AUMED, a.s. will successfully complete clinical trials and register the preparation TFI in several European markets. We hope that in two years we will be able to inform medical professionals about the availability of the preparation on the market.
AUMED, a.s. announces the successful completion of an extensive research and development project (registration number CZ.01.01.01/01/22_002/0000585) aimed at developing an…
A comprehensive review article summarizing the past, present, and future of phage therapy research and practice in the Czech Republic…
Read what they wrote about us. In a new article and an interview with our CEO, we discuss our research…
Research projects of Aumed, a.s. are financed by the European Structural Funds and with financial support from the state budget through the Ministry of Industry and Trade. A complete list of all ongoing and completed projects with this support can be found here.
European Union
European Regional Development Fund
OP Enterprise and Innovation for Competitiveness